Flagship Pioneering
↗Cambridge, USA
Flagship Pioneering is a life sciences venture capital firm and company incubator based in Cambridge, Massachusetts. The firm specializes in inventing, building, and funding first-in-category bioplatform companies within biotechnology, life sciences, health, and sustainability.
Operating through a unique model that blends hypothesis-driven innovation with systematic entrepreneurship, Flagship creates companies in-house through its 'Flagship Labs' unit. Since its founding in 2000, the firm has originated and fostered over 100 scientific ventures, including notable successes like Moderna, generating significant aggregate market value.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:
Industry:Biotechnology
Sub-Industry:Venture Capital / Biotech Incubator
SIZE & FINANCIALS
Employees:201-500
Revenue:$50M-$100M
Founded:2000
Ownership:private
Status:operating
PIPELINE
Stage:Discovery
Lead Drug Stage:Commercial (via portfolio companies like Moderna)
Modalities:mRNA, Small molecule, Cell therapy, Gene editing, Somatic genomics
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Pfizer (Strategic alliance for drug discovery), Novo Nordisk (Innovation supply chain partnership)
COMPETITION
Position:Leader
Competitors:Third Rock Ventures, Atlas Venture, ARCH Venture Partners
LEADERSHIP
Key Executives:
Noubar Afeyan - Founder and CEO
LINKS
Website:flagshippioneering.com
LinkedIn:LinkedIn Profile
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Flagship Pioneering and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Flagship Pioneering. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.